Í»ÆÆèäèô | RMMR·¨¸ßЧºÏ³É¿Õ¼äλ×è¶àëÄ-ÌÚ²©tengbo9885¹ÙÍø" /> Åä¾°ÏÈÈݽüÄêÀ´£¬¶àëÄÒ©ÎïÒòÔÚ¶àÖÖ¼²²¡ÁìÓòÕ¹ÏÖ³öÆæÒìÓÅÊÆ¶ø±¸ÊܹØ×¢£¬µ«Æä½Ï²îµÄÎȹÌÐԺͽϵ͵Äϸ°ûÄ¤ÉøÍ¸ÐÔÑÏÖØÖÆÔ¼Á˶àëÄÒ©ÎïµÄ½øÒ»²½Éú³¤¡£Ñо¿Åú×¢£¬ÔÚ¶àëÄÁ´ÖÐÒýÈë¾ßÓпռäλ×èµÄ°±»ùËᣨÈçN-¼×»ù»¯°±»ùËá¡¢-ÌÚ²©tengbo9885¹ÙÍø" /> Í»ÆÆèäèô | RMMR·¨¸ßЧºÏ³É¿Õ¼äλ×è¶àëÄ-ÌÚ²©tengbo9885¹ÙÍø"> Åä¾°ÏÈÈݽüÄêÀ´£¬¶àëÄÒ©ÎïÒòÔÚ¶àÖÖ¼²²¡ÁìÓòÕ¹ÏÖ³öÆæÒìÓÅÊÆ¶ø±¸ÊܹØ×¢£¬µ«Æä½Ï²îµÄÎȹÌÐԺͽϵ͵Äϸ°ûÄ¤ÉøÍ¸ÐÔÑÏÖØÖÆÔ¼Á˶àëÄÒ©ÎïµÄ½øÒ»²½Éú³¤¡£Ñо¿Åú×¢£¬ÔÚ¶àëÄÁ´ÖÐÒýÈë¾ßÓпռäλ×èµÄ°±»ùËᣨÈçN-¼×»ù»¯°±»ùËá¡¢-ÌÚ²©tengbo9885¹ÙÍø"> ÌÚ²©tengbo9885¹ÙÍø">
ÐÂÎŶ¯Ì¬
½üÄêÀ´£¬¶àëÄÒ©ÎïÒòÔÚ¶àÖÖ¼²²¡ÁìÓòÕ¹ÏÖ³öÆæÒìÓÅÊÆ¶ø±¸ÊܹØ×¢£¬µ«Æä½Ï²îµÄÎȹÌÐԺͽϵ͵Äϸ°ûÄ¤ÉøÍ¸ÐÔÑÏÖØÖÆÔ¼Á˶àëÄÒ©ÎïµÄ½øÒ»²½Éú³¤¡£Ñо¿Åú×¢£¬ÔÚ¶àëÄÁ´ÖÐÒýÈë¾ßÓпռäλ×èµÄ°±»ùËᣨÈçN-¼×»ù»¯°±»ùËá¡¢¦Á,¦Á-¶þÈ¡´ú°±»ùËᣩ£¬¿ÉÒÔÓÐÓÃÌá¸ßëĵÄÎȹÌÐÔºÍÄ¤ÉøÍ¸ÐÔ£¬È»¶ø¹Å°åµÄ¹ÌÏàºÏ³É·¨Òò·Ç¾ùÏà·´Ó¦µÄÌØÕ÷£¬ÔÚÒýÈëÕâЩ°±»ùËáʱ±£´æ·´Ó¦ËÙÂÊÂý£¬Ð§ÂʵÍÒÔ¼°ËõºÏÊÔ¼ÁÏûºÄ´óµÈÎÊÌâ¡£
»ùÓÚÉÏÊöÎÊÌâµÄ±£´æ£¬ÄϾ©´óѧҦף¾üÍŶӿª·¢ÁËÒ»ÖÖ»ùÓÚÄâºËÌÇÌåµÄõ£»ù×ªÒÆ»úÖÆµÄÀο¿»¯·Ö×Ó·´Ó¦Æ÷RMMRs£¨Ribosome mimicking molecular reactors£©¡£
RMMRÊ÷Ö¬ÊÇÒÔRinkõ£°·Ê÷֬Ϊ»ù´¡£¬Í¨¹ýFmoc-LysÑÜÉúÎï¹¹½¨Ê÷֦״ÊèÉ¢µÄ»î»¯Î»µã£¬×îÖÕÀο¿ÓÚAMÊ÷Ö¬ÉÏ£¨Í¼1£©£¬ÆäÈÜÕÍÄÜÁ¦ÓëÉÌÓÃÊ÷Ö¬Ï൱£¬ÇÒÎȹÌÐԺã¬6¸öÔÂÄÚÎÞ½µ½â¡£

ͼ 1 RMMRµÄ×é³É
¸Ã·´Ó¦Æ÷ÊÇͨ¹ýÔÚÊ÷Ö¬ÉÏÅþÁ¬ËĸöôÈ»ù»î»¯Î»µã£¨¼ûͼ2£©ºÍÒ»¸öëĺϳÉλµã£¬ÔÚDICºÍN-Fmoc°±»ùËá±£´æÏÂÐγɶà¸ö»îÐÔõ¥ÖÐÐÄÌ壬Ôö½øN¶Ë°±»ùºÍÏàÁÚ¼¤»îÖÐÐÄÌå¿ìËÙʵÏÖ·Ö×ÓÄÚ»ò·Ö×Ó¼äµÄO¡úNõ£»ù×ªÒÆ£¨½öÓÐÒ»¸öÑõõ£»ù¾ÙÐÐżÁª£©£¬´Ó¶øÌá¸ß¿Õ¼äλ×èëĵĺÏЧ¹ûÂÊ£¬×îºó¾ßßऴ¦Öóͷ££¬¿ÉͬʱÍê³ÉFmoc±£»¤»ùµÄÍѳýºÍδ·´Ó¦µÄ»îÐÔõ¥µÄÔÙÉú¡£Æä×÷ÓûúÖÆÈçÏÂͼ3Ëùʾ¡£

ͼ2 ͨÓûîÐÔ¼¤»îÊÔ¼Á¼°ÆäÑÜÉúÎï

ͼ3 RMMRs×÷ÓûúÖÆ
ÔÚͨÀý¶àëĵĺϳÉÖУ¬»®·Ö½ÓÄÉÒÔOxyma-CºÍHOBt-CΪ»îÐÔλµãµÄRMMAÊ÷Ö¬ºÍÉÌÓÃRink AmideÊ÷Ö¬ºÏ³ÉËÄëÄQ-W-R-K-NH2ºÍ°ËëÄѪ¹ÜÖ÷ÒªËØIIõ£°·£¬Ð§¹û¶ÔºÃ±ÈÏÂ±í¡£
±í1 ²î±ðÊ÷Ö¬ºÏ³ÉËÄëĺͰËëĵÄЧ¹û±ÈÕÕ

×¢£º±íÖÐÊýֵΪ´ÖÆ·´¿¶È
ʵÑéЧ¹ûÅú×¢£¬RMMRÊ÷Ö¬ºÏ³ÉµÄ¶àëÄÔÚÖÊÁ¿ÉÏÓëÉÌÓÃRink AmideÊ÷Ö¬ºÏ³ÉµÄëÄÏ൱¡£±ðµÄ£¬Ê¹ÓÃOxyma-C RMMRÊ÷Ö¬½ÓÄÉÊÖ¶¯ºÏ³ÉģʽµÄ´ÖÆ·´¿¶ÈΪ97%£¬¶ø×Ô¶¯»¯ºÏ³ÉµÄ´¿¶ÈΪ94%£¬Á½ÖÖ²Ù×÷ģʽЧ¹ûÏà½ü¡£
N-¼×»ù»¯ëĵĺϳÉ
Ôںϳɺ¬ÓÐN-¼×»ù»¯°±»ùËáµÄ¶àëÄʱ£¬RMMRÊ÷Ö¬ÏÔÖøÌá¸ßÁËËõºÏЧÂÊ£¬²úÆ·´¿¶È×î¸ß¿ÉÖÁ98%£¬¶øÊ¹ÓÃRink AmideÊ÷Ö¬ËùµÃ²úÆ·´¿¶È´ó¶¼µÍÓÚ20%¡£²¿·ÖʵÀýÈçÏÂͼ4Ëùʾ¡£

ͼ4 ²î±ðÊ÷Ö¬ºÏ³ÉN-¼×»ù»¯¶àëÄ
º¬¦Á,¦Á-¶þÈ¡´úµÄ¶àëĺϳÉ
RMMRÊ÷Ö¬Ôںϳɺ¬ÓЦÁ,¦Á-¶þÈ¡´ú°±»ùËá(ÈçAib£¬¦Á-°±»ùÒì¶¡Ëá)µÄ¶àëÄʱͬÑùÌåÏÖ³öÓÅÒìµÄºÏ³ÉÄÜÁ¦¡£¹ØÓÚº¬ÓÐÁ½¸öÒ»Á¬¦Á,¦Á-¶þÈ¡´ú°±»ùËáµÄÐòÁУ¨ÈçÏÂͼ5£©£¬´¿¶È¿É´ï90%ÒÔÉÏ£¬Ïà¶ÔµÄ£¬ÉÌÓÃRink AmideÊ÷Ö¬ºÜÄÑÓÐÓúϳÉÏìÓ¦µÄ¶àëÄ¡£

ͼ5 ²î±ðÊ÷Ö¬ºÏ³ÉÒ»Á¬¦Á,¦Á-¶þÈ¡´ú¶àëÄ
ÖØ´ó·Ö×Óalamethicin FÀàËÆÎïµÄºÏ³É

ͼ6 alamethicin FÀàËÆÎïµÄºÏ³É
¸ÃÍŶÓΪ½øÒ»²½ÑéÖ¤RMMRÊ÷Ö¬ÔÚÖØ´ó½á¹¹ÖеÄÊÊÓÃÐÔ£¬½ÓÄÉOxyma-C RMMRÊ÷Ö¬ºÏ³ÉÁ˺¬ÓÐ8¸öAib²Ð»ùµÄalamethicin FÀàËÆÎʵÑéЧ¹ûÅú×¢£¬RMMRÊ÷Ö¬¶ÔÖØ´ó¿Õ¼äλ×è¶àëÄͬÑù¸ßЧ£ºËùµÃ´ÖÆ·´¿¶È¿ÉÒԸߴï88%£¬ÆäÊèÉ¢ÊÕÂÊÒ²µÖ´ïÁË73%¡£
ÉÏÊöʵÑéÅú×¢£¬RMMRϵÁÐÊ÷֬ͨ¹ýÆäÀο¿»¯õ£»ù×ªÒÆ»úÖÆ£¬Í»ÆÆÁ˹Űå¹ÌÏàºÏ³ÉÔÚÖÆ±¸¿Õ¼äλ×èëÄʱµÄ¾ÖÏÞ£¬ÏÔÖøÌá¸ßÁËËõºÏЧÂÊ¡£
RMMRϵÁÐÊ÷֬ͨ¹ýÄ£ÄâºËÌÇÌåµÄõ£»ù×ªÒÆ»úÖÆ£¬ÎªºÏ³É¾ßÓÐÒ©ÓÃDZÁ¦µÄ¿Õ¼äλ×èëÄÌṩÁËÒ»ÖÖ¸ßЧÇÒ¿É¿¿µÄ½â¾ö¼Æ»®£¬ÌØÊâÊÇÔÚÒýÈëN-¼×»ù»¯ºÍ¦Á,¦Á-¶þÈ¡´ú°±»ùËá·½ÃæÌåÏÖ¾«²Ê¡£ÁíÍ⣬ӦÓôËϵÁÐÊ÷Ö¬ºÏ³ÉÌôÕ½ÐÔ°±»ùËᣬ½öÐèʹÓÃÉÌÒµ»¯µÄFmoc°±»ùËáºÍDICÊÔ¼Á£¬Í¬Ê±¼æÈÝÊÖ¶¯ºÍ×Ô¶¯ºÏ³Éģʽ£¬Õ¹ÏÖ³öÁÉÀ«µÄÓ¦ÓÃÔ¶¾°¡£
¾ÓÉ22ÄêµÄ²»Ð¸Æð¾¢ºÍ»ýÀÛ£¬ÌÚ²©tengbo9885¹ÙÍøÉúÎïÔÚÈ«Çò¶àëĺϳÉÊÔ¼ÁÁìÓòÒ»Á¬Éî¸û£¬ÏÖÒÑÉú³¤³ÉΪ¾ßÓÐÆÕ±é¶¨ÖÆ²úÆ·ÁýÕÖÄÜÁ¦ºÍÏÔÖø¹æÄ£»¯Éú²úÓÅÊÆµÄÁìÏÈÆóÒµ£¬¿ÉÒÔÖª×ãÖÖÖÖ¿Í»§µÄÌØ¶¨ÐèÇó¡£ÎÒÃÇÕæÖ¿Ô¼Çë¶Ô¸Ã²úÆ·¸ÐÐËȤµÄ¿Í»§ÓëÎÒÃÇÁªÏµ£¬ÒÔ±ã½øÒ»²½Ïàʶ²úÆ·ÏêÇ飬²¢Ì½ÌÖºÏ×÷»ú»á¡£
²Î¿¼ÎÄÏ×£º
[1] Wei, S.; Zhang, X.; Yao, Z., et al. Immobilized acyl-transfer molecular reactors enable the solid-phase synthesis of sterically hindered peptides[J]. Nat. Chem. 2025, 17, 1596?1606.
